subject area of

• A Summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses  Other Publication
• A novel assay for detection of hepatitis C virus-specific effector CD4 + T cells via co-expression of CD25 and CD134  Academic Article
• Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia  Academic Article
• Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study  Academic Article
• Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection  Academic Article
• An urgent need to scale-up injecting drug harm reduction services in Tanzania: Prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011  Academic Article
• Behavioural research to inform understanding of hepatitis C resistance  Letter
• Blood and bioidentity: ideas about self, boundaries and risk among blood donors and people living with Hepatitis C  Academic Article
• Blood-borne viral STIs.  Academic Article
• Buprenorphine injection in Melbourne, Australia - an update  Academic Article
• Can we include genetic variants with high linkage disequilibrium into a multiple logistic model? [Letter]  Letter
• Case definitions for acute hepatitis C virus infection: A systematic review  Academic Article
• Change in hepatitis C virus genotype in injecting drug users  Academic Article
• Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study  Academic Article
• Claims and compensation for complications resulting from blood transfusions in China from 1998 to 2013  Academic Article
• Community-Based Provision of Direct-Acting Antiviral Therapy for Hepatitis C: Study Protocol and Challenges of a Randomized Controlled Trial  Academic Article
• Delivering the hepatitis C cure to Aboriginal people: documenting the perspectives of one Aboriginal Health Service  Academic Article
• Differences in the social networks of ethnic Vietnamese and non-Vietnamese injecting drug users and their implications for blood-borne virus transmission  Academic Article
• Direct-acting antiviral agents for HCV infection affecting people who inject drugs  Academic Article
• Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with "illegal social behaviour"  Academic Article
• Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study  Academic Article
• Drug, sex and sociality: Factors associated with the recent sharing of injecting equipment among gay and bisexual men in Australia  Academic Article
• Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection  Academic Article
• Elimination of Hepatitis C Virus in Australia: Laying the Foundation  Academic Article
• Engagement, reciprocity and advocacy: ethical harm reduction practice in research with injecting drug users  Academic Article
• Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: A multicenter study  Academic Article
• Eradicating hepatitis C: the need for a public health response  Academic Article
• Ethnic and cultural determinants influence risk assessment for hepatitis C acquisition  Academic Article
• Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay  Academic Article
• Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study  Academic Article
• Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study  Academic Article
• HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs  Academic Article
• HCV avidity as a tool for detection of recent HCV infection: Sensitivity depends on HCV genotype  Academic Article
• HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection  Academic Article
• HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection  Academic Article
• Harm reduction workers and the challenge of engaging couples who inject drugs in hepatitis C prevention  Academic Article
• Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments  Academic Article
• Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs  Academic Article
• Hepatitis C knowledge among gay and other homosexually active men in Australia  Academic Article
• Hepatitis C transmission and treatment as prevention - The role of the injecting network  Academic Article
• Hepatitis C treatment as prevention: evidence, feasibility, and challenges  Academic Article
• Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view  Academic Article
• Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse  Academic Article
• Hepatitis C virus notification rates in Australia are highest in socioeconomically disadvantaged areas  Academic Article
• Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosis  Academic Article
• Hepatitis C — Role of Perinatal Transmission  Academic Article
• Hepatitis C-induced hepatocyte apoptosis following liver transplantation is enhanced by immunosuppressive agents  Academic Article
• Hepatitis c virus reinfection and spontaneous clearance of reinfection - The InC³ study  Conference Paper
• High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study  Academic Article
• Higher incidence of HCV in females compared to males who inject drugs: a systematic review and meta-analysis  Academic Article
• ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response  Academic Article
• Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis  Academic Article
• Individual-level needle and syringe coverage in Melbourne, Australia: a longitudinal, descriptive analysis  Academic Article
• Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study  Academic Article
• Injecting drug use among gay and bisexual men in Sydney: Prevalence and associations with sexual risk practices and HIV and hepatitis C infection  Academic Article
• Integrating enhanced hepatitis C testing and counselling in research  Academic Article
• Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC3 Study  Academic Article
• Interferon λ 3 and 4 genotyping using high-resolution melt curve analysis suitable for multiple clinical sample types  Academic Article
• Interferon-α in Hepatitis C  Academic Article
• Interferon-α in Hepatitis C  Academic Article
• Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review  Academic Article
• Jugular venipuncture and other innovative approaches to phlebotomy among people who inject drugs  Comment
• Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre  Academic Article
• Longitudinal analysis of change in individual-level needle and syringe coverage amongst a cohort of people who inject drugs in Melbourne, Australia  Academic Article
• Management of acute HCV infection in the era of direct-acting antiviral therapy  Academic Article
• Missed Opportunities for Hepatitis C Testing and Other Opportunistic Health Care  Letter
• Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users  Academic Article
• Molecular Epidemiology of Hepatitis C Virus in a Social Network of Injection Drug Users  Academic Article
• Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012  Academic Article
• Multiple strategies are required to address the information and support needs of gay and bisexual men with hepatitis C in Australia  Academic Article
• Naloxone distribution: Remembering hepatitis C transmission as an issue [5]  Academic Article
• New hepatitis C antiviral treatments eliminate the virus  Letter
• Now, later or never? Challenges associated with hepatitis C treatment  Academic Article
• Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study  Academic Article
• Opportunistic and continuing health care for injecting drug users from a nurse-run needle syringe program-based primary health-care clinic  Letter
• Patterns of hepatitis C Virus RNA levels during acute infection: The InC3 study  Academic Article
• Pharmacies dispensing opioid substitution therapy also play a role in hepatitis C virus elimination  Letter
• Pharmacy-led hepatitis C treatment pathways to help ensure elimination  Letter
• Practices of partnership: Negotiated safety among couples who inject drugs  Academic Article
• Prevalence and Correlates of Three Types of Pelvic Pain in a Nationally Representative Sample of Australian Men  Academic Article
• Prevalence and risk factors of hepatitis C in HIV-negative homosexual men in Sydney, Australia  Academic Article
• Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients  Academic Article
• Prevalence, incidence and risk factors for hepatitis C in homosexual men: data from two cohorts of HIV-negative and HIV-positive men in Sydney, Australia  Academic Article
• Recognition of Hepatitis C Virus Coinfection in HIV-Positive Injecting Drug Users in Asia  Academic Article
• Remarkable difference in the mode of HCV transmission among haemodialysis patients and IVDAs [7]  Academic Article
• Risk behaviours and blood borne virus exposure for transient workers in rural Victoria  Academic Article
• Risk behaviours of young Indo-Chinese injecting drug users in Sydney and Melbourne  Academic Article
• Severe vein damage caused by Temezepam injecting  Academic Article
• Social inclusion and hepatitis C: exploring new possibilities for prevention  Academic Article
• The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative  Academic Article
• The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia  Academic Article
• The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C  Academic Article
• The cost of hepatitis C and the cost–effectiveness of its prevention  Academic Article
• The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection  Academic Article
• The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs  Academic Article
• The impact of injecting networks on hepatitis c transmission and treatment in people who inject drugs  Academic Article
• The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis C virus entry  Academic Article
• The intimate relationship as a site of social protection: Partnerships between people who inject drugs  Academic Article
• The missing mass of morality: A new fitpack design for hepatitis C prevention in sexual partnerships  Academic Article
• The ongoing impacts of hepatitis c - a systematic narrative review of the literature  Academic Article
• The prevalence and risk behaviours associated with the transmission of blood-borne viruses among ethnic-Vietnamese injecting drug users  Academic Article
• The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy  Academic Article
• Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: a population-based study  Academic Article
• Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus Infection  Academic Article
• Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000–2014)  Academic Article
• Venue-based networks may underpin HCV transmissions amongst HIV-infected gay and bisexual men  Academic Article
• Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C  Academic Article
• ‘Affording’ new approaches to couples who inject drugs: A novel fitpack design for hepatitis C prevention  Academic Article
• ‘It’s Your Life!’: Injecting Drug Users, Individual Responsibility and Hepatitis C Prevention  Academic Article
• “Don’t think I’m going to leave you over it”: Accounts of changing hepatitis C status among couples who inject drugs  Academic Article
• “I'm obviously not dying so it's not something I need to sort out today”: Considering hepatitis C treatment in the era of direct acting antivirals  Academic Article